BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Raza IJ, Tingate CA, Gkolia P, Romero L, Tee JW, Hunn MK. Blood Biomarkers of Glioma in Response Assessment Including Pseudoprogression and Other Treatment Effects: A Systematic Review. Front Oncol 2020;10:1191. [PMID: 32923382 DOI: 10.3389/fonc.2020.01191] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Le Fèvre C, Constans JM, Chambrelant I, Antoni D, Bund C, Leroy-Freschini B, Schott R, Cebula H, Noël G. Pseudoprogression versus true progression in glioblastoma patients: A multiapproach literature review. Part 2 - Radiological features and metric markers. Crit Rev Oncol Hematol 2021;159:103230. [PMID: 33515701 DOI: 10.1016/j.critrevonc.2021.103230] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
2 Xi J, Hassan B, Katumba RGN, Khaddour K, Govindan A, Luo J, Huang J, Campian JL. The predictive value of absolute lymphocyte counts on tumor progression and pseudoprogression in patients with glioblastoma. BMC Cancer 2021;21:285. [PMID: 33726710 DOI: 10.1186/s12885-021-08004-2] [Reference Citation Analysis]
3 Lu W, Chen H, Liang B, Ou C, Zhang M, Yue Q, Xie J. Integrative Analyses and Verification of the Expression and Prognostic Significance for RCN1 in Glioblastoma Multiforme. Front Mol Biosci 2021;8:736947. [PMID: 34722631 DOI: 10.3389/fmolb.2021.736947] [Reference Citation Analysis]
4 Ali H, Harting R, de Vries R, Ali M, Wurdinger T, Best MG. Blood-Based Biomarkers for Glioma in the Context of Gliomagenesis: A Systematic Review. Front Oncol 2021;11:665235. [PMID: 34150629 DOI: 10.3389/fonc.2021.665235] [Cited by in F6Publishing: 1] [Reference Citation Analysis]